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Abstract 
Background: Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae have been reported previously from Pakistan but 
the genotypic characteristics of these enzymes is not known. Hence the aim of the study was first to characterise the genotypic content of 
these beta-lactamases and secondly to assess the clonal relationship of these isolates.  
Methodology: We analysed 65 non-duplicate ESBL positive, K. pneumoniae isolates prospectively collected based on phenotype as detected 
using the two-disc method. Isolates were collected from different sources: blood cultures (46.15%; n = 30); tracheal aspirates (24.6%; n = 
16); urine (10.7%; n = 7); wound swabs, pus and tissue (18.4%; n = 12). ESBL production was confirmed by the ESBL E-test method and the 
presence of the blaCTX-M encoding genes was confirmed by polymerase chain reaction. The clonal relationship of clinical isolates was studied 
by Pulsed Field Gel Electrophoresis.  
Results: The results showed that 93.84% (n = 61) isolates of K. pneumoniae were positive for the blaCTX-M-1 group. One isolate showed PCR 
signals for blaCTX-M-25 group. None of our isolates were positive for CTX-M groups 2, 8 and 9. The majority of blaCTX-M positive isolates 
were genetically unrelated and no epidemic clones were identified. Conclusion: This study reports the emergence of CTX-M groups 1 and 25 
producing isolates of K. pneumoniae with genetic diversity in Karachi, Pakistan. 
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Introduction 
Extended-spectrum β-lactamase (ESBL) 
producing strains of Klebsiella pneumoniae were first 
detected in Germany in 1983 [1]. Today multi drug 
resistant K. pneumoniae is recognised as a global 
challenge, with the potential to develop resistance to 
all available antibiotic armamentarium [2]. 
Most ESBLs are mutants of classical TEM and 
SHV genes. These mutations allow them to 
hydrolyze extended spectrum antibiotics. More than 
150 TEM enzymes and more than 50 different 
mutants of SHV have been reported [3]. A recently 
discovered family of plasmid mediated ESBLs called 
CTX-Ms, which preferentially hydrolyze cefotaxime, 
has emerged in several continents around the world 
[3,4]. More than 40 different variants of CTX-M 
enzymes are currently known. 
ESBL producing isolates of K. pneumoniae have 
been reported from Pakistan previously by Shah et al. 
[5]. In this study an analysis of 400 isolates of 
Enterobacteriaceae for ESBL production identified 
that 70% of K. pneumoniae isolates were found 
positive for ESBL production [5]. However, another 
study by Mirza et al. identified only 4 out of 50 
clinical isolates of E. coli as positive for CTX-M 
phenotype using the double disc method and MIC 
break points [6]. Neither study, however, performed 
genetic characterization of CTX-M enzyme types 
produced by these isolates. 
At the clinical microbiology laboratory of the 
Aga Khan University Hospital (AKUH), K. 
pneumoniae is the most common Enterobacteriaceae 
and is associated with multiple drug resistance, 
including the third-generation cephalosporins.  In K. 
pneumoniae, resistance to cephalosporins mediated 
by ESBL has dramatically increased over the years 
from 22.9% in 2002 to 37% in 2007 (AKU 
unpublished data). Hence in our current study we 
evaluated the genetic characterization of CTX-M 
enzymes in clinical isolates of K. pneumoniae and 
sought to determine their clonal relationship as an 
endemic strain to ascertain the possible emergence of 
a clonal strain. 
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Materials and methods 
AKUH is a 550-bedded university hospital that 
includes a 12-bed adult ICU and an 8-bed neonatal 
ICU. All ESBL producing isolates of K. pneumoniae 
that were identified on a two disc screening method 
were confirmed biochemically using API-20E 
analytical system [7]. These isolates were 
prospectively collected over period of one year 
(2007-08) and stored at -80oC. 
 
Bacterial isolate and susceptibility testing 
Antimicrobial susceptibility testing was 
performed by the Kirby Bauer method per the 
Clinical and Laboratory Standards Institute (CLSI) 
guidelines [8]. Antimicrobial discs tested were 
ampicillin (10 µg), amoxicillin/clavulanic acid (20/10 
µg), piperacillin/tazobactam (100/10 µg), cefotaxime 
(30 µg), ceftazidime (30 µg), cefepime (30 µg) 
aztreonam (30 µg), gentamicin (10 µg), amikacin (30 
µg), ofloxacin (5 µg), trimethoprim/sulfamethoxazole 
(1.25/23.75 µg), and imipenem (10 µg). Resistance to 
tigecycline was ascertained using the disc testing as 
outlined by the British Society for Antimicrobial 
Chemotherapy (BSAC) guidelines. Escherichia coli 
ATTC 25922 was used as the quality control strain. 
 
ESBL screening 
Isolates were screened for ESBL production 
using the double disc synergy test using aztreonam 
(30 μg) and amoxicillin clavulanate (10 μg). ESBL 
production was deduced when the zone of aztreonam 
was expanded by clavulanate. In order to confirm this 
ESBL production, the ESBL E-test method (AB-
Biodisk, Solna, Sweden) was conducted. In this test, 
ESBL detection was concluded if the MIC ratio for 
cefotaxime alone (cefotaxime + clavulanate) was 
greater than 8, following the manufacturer’s 
instructions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Detection of blaCTX-M gene by PCR 
Isolates with an ESBL phenotype were further 
investigated for blaCTX-M alleles using primers 
specific for each of the five groups of CTX-M 
primers as described by Woodford et al. [9]. E. coli 
NCTC 13353 was used as a positive control. Table 1 
shows details of the primer sequences used for each 
group. Amplification conditions for CTX-M groups 
(1, 2, 8 and 9) were as follows: early denatured at 
94°C for 10 minutes followed by 30 cycles of 94°C 
for 1 minute, 58°C for 1 minute and 72°C for 1 
minute, with a final elongation step of 10 minutes at 
72°C. For CTX-M group 25 the PCR conditions were 
as follows: initial denaturation at 94°C for 5 minutes 
followed by 40 cycles of 94°C for 25 seconds, 60°C 
for 40 seconds, and 72°C for 50 seconds, with 
ultimate extension step of 10 minutes at 72°C. 
Results of PCR analysis were reconfirmed at the 
Centre of Infectious Disease, University of 
Edinburgh, United Kingdom. 
 
Pulsed field gel electrophoresis (PFGE): 
The clonal relationship of the clinical isolates 
was studied by PFGE, as previously reported [10]. 
Briefly, 1 ml of overnight culture broth was taken and 
resuspended in Pett IV solution (1 M NaCl, 10mM 
Tris [pH 7.5]). The suspensions were mixed with an 
equivalent volume of 1.3%. Low melting point 
agarose (Sigma, Saint Louis, Missouri, USA) was 
solidified in moulds (BioRad, California, USA) to 
make plugs. These plugs were transferred to 2 ml of 
lysis buffer (0.1M EDTA, 1M NaCl, 0.5% brij 58, 
0.2% deoxycholate and 05% of sarcosine) containing 
1 mg/ml of lysozyme and 10 mg/ml of RNase A 
(Invitrogen, NY, USA) and incubated at 37˚C for 18-
20 hrs. The next day, lysis buffer was removed and 
plugs were incubated at 55˚C for 24 hours in 2 ml of 
ESP buffer (0.5M EDTA, 1% sarcosine) along with 
100mg/ml of Proteinase K (Promega, Madison, 
USA). The plugs were then washed four  
Primer [9]                      Sequence   Amplicon size 
CTXM GP 1 F    
CTXM GP 1 R                       
5΄-AAAAATCACTGCGCCAGTTC-3΄ 
5΄-AGCTTATTCATCGCCACGTT-3΄                               
415bp 
CTXM GP 2 F  
CTXM GP 2 R                            
5΄-CGACGCTACCCCTGCTATT-3΄ 
5΄-CCAGCGTCAGATTTTTCAGG-3΄ 
552bp 
CXTM GP 9 F               
CTXM GP 9 R              
5΄-CAAAGAGAGTGCAACGGATG-3 
5΄-ATTGGAAAGCGTTCATCACC-3΄ 
205bp 
CTXM GP 8 F               5΄-TCGCGTTAAGCGGATGATGC-3 666bp 
CTXM GP 25 F             
CTXM GP 8/25* R         
5΄-GCACGATGACATTCGGG-3΄ 
5΄-AACCCACGATGTGGGTAGC-3΄ 
                                   
327bp 
Table 1. Primers used for amplification 
 
F= Forward Primer, R=Reversed Primer,   *: GP 8/25 shares reversed primer. [9]  
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times with 20 ml of TE buffer and digested with 20 U 
of Xba 1 for 24 hours at 37˚C. Fragments of DNA 
were separated in 1% agarose gel (Pulse Field 
Certified Agarose-Bio Rad) using CHEF DRIII 
apparatus (Bio Rad) under the following conditions: 
6V/cm2 for 22 hours at 14˚C, with initial pulse time 
of 2 seconds and final pulse time of 35 seconds. 
Photographs of ethidium bromide stained gels were 
examined visually. DNA band patterns were read 
according to criteria defined by Tenover et al. as 
follows: indistinguishable; no variation in DNA band 
fragment; closely related: variation in 2-3 bands and 
unrelated; variation > 3 bands [11]. 
 
Results 
A total of 65 non-duplicate ESBL positive, K. 
pneumoniae were prospectively collected based on 
their phenotype as detected using the two disc 
method. The majority of the isolates were from blood 
cultures (46.15%; n = 30) followed by tracheal 
aspirates (24.6%; n = 16), urine (10.7%; n = 7) while 
cultures from catheter tips, wound swabs, tissue and 
pus together constituted 18.4% (n = 12). The majority 
of isolates were yielded from patients admitted to the 
neonatal intensive care unit 18.46% (n = 12) followed 
by the medical wards 15.38% (n = 10), adult ICU 
13.84% (n = 9) and the pediatric unit 10.76% (n = 7). 
The exact hospital location for 12 patients could not 
be ascertained as patients were shifted to different 
wards during the duration of their hospital stay. 
 
 
 
Detection of blaCTX-M gene 
Sixty-one (93.84%) isolates of K. pneumoniae 
were positive for blaCTX-M-1 group alleles. Only one 
isolate showed PCR signals for blaCTX-M-25 group 
alleles. None of our isolates were positive for CTX-
M groups 2, 8 and 9 (Figure 1) 
 
Pulsed field gel electrophoresis 
In general, molecular typing revealed 
considerable genetic diversity among the clinical 
isolates (Figure 2); however, some PFGE patterns 
were found to be associated with isolates obtained 
from the adult ICU. This trend was not apparent with 
isolates obtained from NICU. Among the ICU cohort 
strains, ICU1-2 and ICU6-9 were found to be 
indistinguishable; hence they were deemed to be 
closely related (Figure: 2A). In the case of the NICU 
strains, two isolates NICU5-6 (Figure: 2B) appeared 
indistinguishable while the others showed more than 
three band variations and as such were considered 
unrelated. 
 
 
 
 
 
 
 
 
Figure 1. PCR gel picture of blaCTXM-1 alleles of  
K. pneumoniae isolates 
Lanes: 1. 100bp ladder, 2. Positive control blaCTXM-1, 3 to 12. Clinical isolates, 13. Negative control 
(Ecoli j53), 14. Blank 
Figure 2. A representative pulse field gel electrophoresis (PFGE) 
profile of Xbal-digested genomic DNA from CTXM ESBL producing 
isolates 
A) Corresponds to isolates from ICU. Four Isolates in this cohort  (lanes 6,7,8,9) showed identical 
patterns  
B) Shows gel pictures of isolates from  NICU, two strains (lanes 5 and 6) showed identical PFGE 
patterns 
Khan et al. – Tertiary care emergence of Klebsiella pneumonia      J Infect Dev Ctries 2010; 4(8):472-476. 
 
475 
 
Susceptibility patterns 
Table 2 shows details of the susceptibility 
profiles of the blaCTX-M-1 producing K. pneumoniae to 
different antibiotics. Among the beta-lactam drugs 
96% were found resistant to ampicillin. Resistance to 
beta-lactamase inhibitor combinations such as 
Augmentin and Pipracillin Tazobactam was also 
significant (see Table 2). Among the non-beta-lactam 
group of antibiotics, 83.6% were resistant to 
cotrimoxazole, while 85.24% and 36% were resistant 
to gentamicin and amikacin respectively. Resistance 
to ciprofloxacin was noted as 49%. None of the 
isolates were found resistant to imipenem; however, 
21 % were found resistant to tigecycline, which has 
been recently introduced in our hospital formulary. 
 
 
 
 
 
 
 
Discussion 
ESBL producing isolates of K. pneumoniae have 
been reported from different hospitals in Pakistan [5]; 
however, the molecular characterization of the types 
of ESBL enzymes has not been performed 
previously. This is the first study from Pakistan that 
reports the emergence of CTX-M producing isolates 
of K. pneumoniae in a tertiary care centre. 
The majority of the isolates in our study were 
acquired from blood samples followed by the 
respiratory specimens, signifying true infections. This 
is significant as most of these samples were from 
patients in the intensive care units of Aga Khan 
Hospital, putting them at high risk for ventilator-
associated pneumonia and bacteremia due to Gram-
negative rods. 
Ninety-three percent of ESBL positive isolates 
were positive for CTX-M group 1 by PCR, whereas 
only one isolate was positive for CTX-M group-25. 
CTX-M-1 group includes six plasmid mediated 
variants (CTX-M-1, CTX-M-3, CTX-M-10, CTX-M-
12, CTX-M-15 and FEC-1) which have been 
identified in Enterobacteriaceae globally, including in 
Asia [12-14]. 
The spread of ESBL isolates within hospitals is 
of particular concern. The blaCTX-M positive isolates 
were tested by PFGE to determine clonal 
relationships. Most of the isolates tested were found 
to be genetically unrelated and no definite epidemic 
strains were found within the hospital. Few isolates, 
however, did show genetic relatedness. These were 
collected as a part of outbreak investigations during 
the study period. 
Dissemination of genetically diverse strains of 
ESBL producing Enterobacteriaceae is not 
uncommon, as similar findings have been reported 
previously. Thailand has reported the spread of CTX-
M-14 type ESBL in K. pneumoniae isolates with high 
genetic diversity [14]. Plasmid conjugation studies 
have confirmed the potential involvement of ISEcp1 
in the mobility of blaCTX-M between different bacterial 
strains [15]. However, the prevalence of these 
enzymes in unrelated strains implicates the role of 
mobile genetic elements, such as plasmids, and 
insertion sequences, such as ISEcp1, and suggests a 
potential for accelerated dissemination of these 
resistance determinants [15] to other bacteria, such as 
Salmonella typhi, Vibrio cholerae and Shigella 
species which are endemic in our country. Further 
studies are underway to detect the presence of 
ISEcp1 in our isolates. 
The expression of co-resistance and/or the co-
transfer of resistant determinants is probable in our 
isolates as majority of the CTX-M-1 group positive 
isolates were resistant to non-beta-lactam antibiotics 
as reported by others [10,12-13]. Of particular 
interest was the resistance to antibiotics such as 
tigecycline, which has been introduced recently in 
our hospital formulary. None of the isolates were 
found resistant to carbapenem suggesting its 
importance in the treatment of these newly emerging 
CTX-M-1 group positive strains in our hospital. 
In conclusion, this study reports the emergence of 
CTX-M groups 1 and 25 producing isolates of K. 
pneumoniae with genetic diversity in a major tertiary 
care facility in Pakistan. This finding underscores the 
need for the judicial use of antibiotics, especially 
third-generation cephalosporin, as well as good 
hospital infection control practices to curtail the 
spread of these resistant organisms. 
 
Antibiotic tested % Resistance 
Amikacin 36.05 
Aztreonam 77.00 
Gentamicin 85.24 
Ciprofloxacin 49.18 
Ampicillin 96.00 
Augmentin 60.00 
Cotrimoxazole 83.60 
Piperacillin-tazobactam 39.34 
Imipenem 00.00 
Tigecycline 21.30 
Table 2. Percent resistance to different groups of antibiotics 
of 61 K.P Isolates positive for blaCTXM-1 allele, detected at 
Clinical Laboratory Aga Khan University Hospital, Karachi, 
Pakistan.  
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